General description
A certified solution standard suitable for use in LC/MS or GC/MS
applications for pharmaceutical research, clinical toxicology, or
forensic testing. Marketed as the antidepressant drug Viibryd®,
vilazodone is a new serotonin reuptake inhibitor approved by the US
Food and Drug Administration (FDA) on January 21, 2011, for the
treatment of major depressive disorder.
Legal Information
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation
VIIBRYD is a registered trademark of Forest Laboratories, Inc.